Comparison 2. Artemether‐lumefantrine vs chloroquine plus sulfadoxine‐pyrimethamine.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Total failure by day 28	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2 Total failure by days 42, 14, and 7	2		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 Day 42	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2.2 Day 14	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2.3 Day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Gametocyte carriage on days 28, 14, and 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 Day 28	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 Day 14	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.3 Day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]